132 related articles for article (PubMed ID: 20131107)
1. New concepts regarding cerebral vasospasm: glial-centric mechanisms.
Mutch WA
Can J Anaesth; 2010 May; 57(5):479-89. PubMed ID: 20131107
[TBL] [Abstract][Full Text] [Related]
2. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
4. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
Sakowitz OW; Unterberg AW
Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
[TBL] [Abstract][Full Text] [Related]
5. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
Darwish RS; Ahn E; Amiridze NS
J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
Suhardja A
Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
[TBL] [Abstract][Full Text] [Related]
7. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
8. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
Liu-Deryke X; Rhoney DH
Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
[TBL] [Abstract][Full Text] [Related]
9. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
Pluta RM
Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454
[TBL] [Abstract][Full Text] [Related]
10. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
Zemke D; Farooq MU; Mohammed Yahia A; Majid A
Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
[TBL] [Abstract][Full Text] [Related]
11. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic manipulation in the neuro-intensive care unit: cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm.
Diringer MN; Axelrod Y
Curr Opin Crit Care; 2007 Apr; 13(2):156-62. PubMed ID: 17327736
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
14. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective.
Chittiboina P; Conrad S; McCarthy P; Nanda A; Guthikonda B
World Neurosurg; 2011; 75(5-6):660-4. PubMed ID: 21704933
[TBL] [Abstract][Full Text] [Related]
16. [Systemic treatments of the vasospasm].
Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
[TBL] [Abstract][Full Text] [Related]
17. Neuroendovascular management of vasospasm following aneurysmal subarachnoid hemorrhage.
Jabbour PM; Tjoumakaris SI; Rosenwasser RH
Neurosurg Clin N Am; 2009 Oct; 20(4):441-6. PubMed ID: 19853803
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and cerebral vasospasm after subarachnoid hemorrhage.
Pradilla G; Chaichana KL; Hoang S; Huang J; Tamargo RJ
Neurosurg Clin N Am; 2010 Apr; 21(2):365-79. PubMed ID: 20380976
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage.
Woszczyk A; Deinsberger W; Böker DK
Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885
[TBL] [Abstract][Full Text] [Related]
20. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Findlay JM; Macdonald RL; Weir BK
Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
